Frontiers in cellular and infection microbiology · 2026
Epidemiological and immunological insights into respiratory infections in post-COVID-19.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Ziyi, Li Yi, Cai Jianpiao, Sun Yujie, Maimaiti Mulatijiang, Liu Yiwei, Yang Chenglin, Liu Wenjing, Li Sabrina, Ren Yi, Chen Yu, Yang Qiwen, Xu Yingchun, Yi Jie
Аннотация
INTRODUCTION: Post-COVID-19 respiratory infection dynamics require updated epidemiological characterization to inform clinical surveillance and public health strategy.
METHODS: We analyzed 2484 patients with respiratory tract infections (September 2023-February 2024) using comprehensive pathogen screening (29 viral, bacterial, and atypical targets) and cytokine quantification (12 cytokines).
RESULTS: Overall pathogen detection was 70.73%, with viral and bacterial identification in 40.42%(1004/2484), 51.45%(1278/2484) of cases respectively, and co-infections in 31.88% (predominantly Haemophilus influenzae-virus). Pediatric patients (<18 years) showed significantly higher positivity (74.1% vs. 63.2%, P < 0.05) with viral predominance (41.57% vs. 37.84%), while adults showed bacterial predominance (57.38% vs. 38.23%). Pneumonia risk exhibited age-pathogen specificity: Mycoplasma pneumoniae posed the highest risk in children (41.1% pneumonia rate) versus influenza B in adults (10.2% detection rate). Retrospective cytokine analysis (pre-pandemic 2018-2019 vs. post-pandemic 2023-2024) revealed post-pandemic suppression of IL-6 (6.12 vs.3.82 pg/mL) and IL-8 (37.98 vs. 18.35 pg/mL), with resurgence in 2024, particularly in pediatric and pneumonia cases (P<0.05).
DISCUSSION: Post-pandemic respiratory pathogen epidemiology is characterized by heightened pediatric susceptibility to viral co-infections, bacterial pathogen persistence despite control measures, and dysregulated inflammatory responses. These findings warrant age-stratified diagnostic and surveillance approaches with adaptive public health strategies to reduce respiratory infection morbidity.
METHODS: We analyzed 2484 patients with respiratory tract infections (September 2023-February 2024) using comprehensive pathogen screening (29 viral, bacterial, and atypical targets) and cytokine quantification (12 cytokines).
RESULTS: Overall pathogen detection was 70.73%, with viral and bacterial identification in 40.42%(1004/2484), 51.45%(1278/2484) of cases respectively, and co-infections in 31.88% (predominantly Haemophilus influenzae-virus). Pediatric patients (<18 years) showed significantly higher positivity (74.1% vs. 63.2%, P < 0.05) with viral predominance (41.57% vs. 37.84%), while adults showed bacterial predominance (57.38% vs. 38.23%). Pneumonia risk exhibited age-pathogen specificity: Mycoplasma pneumoniae posed the highest risk in children (41.1% pneumonia rate) versus influenza B in adults (10.2% detection rate). Retrospective cytokine analysis (pre-pandemic 2018-2019 vs. post-pandemic 2023-2024) revealed post-pandemic suppression of IL-6 (6.12 vs.3.82 pg/mL) and IL-8 (37.98 vs. 18.35 pg/mL), with resurgence in 2024, particularly in pediatric and pneumonia cases (P<0.05).
DISCUSSION: Post-pandemic respiratory pathogen epidemiology is characterized by heightened pediatric susceptibility to viral co-infections, bacterial pathogen persistence despite control measures, and dysregulated inflammatory responses. These findings warrant age-stratified diagnostic and surveillance approaches with adaptive public health strategies to reduce respiratory infection morbidity.